Transcript
Good morning and welcome to today's brief news update. Today we explore the hidden price of failed clinical trials. When a promising treatment does not succeed, companies may lose nearly a billion dollars on a single trial, and across certain areas such as cancer research, the annual cost can soar into the tens of billions of dollars. In addition to the huge financial drain, failed trials impose serious ethical burdens. Patients who volunteer for trials face risks and disappointments while companies confront job losses and a loss of public trust. There is also the important matter of opportunity cost. Money wasted on trials that never succeed could otherwise fund research that might save lives or improve patient care. In simple terms, every failed study not only drains resources but also reduces the potential to advance new, life-changing treatments. Stay tuned for more insights on how the industry is working to turn these challenges into opportunities for better research and improved patient safety.
Get more accurate answers with Super Search, upload files, personalized discovery feed, save searches and contribute to the PandiPedia.
Let's look at alternatives:
- Modify the query.
- Start a new thread.
- Remove sources (if manually added).
